MIAMI--(BUSINESS WIRE)--ShiftPixy, Inc. (Nasdaq: PIXY) (“ShiftPixy” or the “Company”), a Florida-based national human capital provisioning enterprise which designs, manages, and sells access to a ...
Activated T cells play an important role in the inflammatory process. Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb), binds to the T cell receptor and dampens inflammation by ...
Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...
Webull delivered one of its strongest quarters since going public — revenue accelerated to 55% YoY, trading-related revenue surged 64%, and the company posted $36.7M in adjusted operating profit, a ...
About Webull FinancialWebull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading ...
Mean Target Price: $18.50 Median Target Price: $18.50 High/Low Range: $19.00 / $18.00 Number of Analysts: 2 Rating: Buy (1.00) — the strongest rating on the scale Analysts covering BULL see the stock ...
Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has ...
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback